MERIDIAN, ID is pleased to announce that it has been selected by Nueterra Healthcare as a "preferred supplier" to supply Nueterra Healthcare with anesthetic gas products. Effective February 8, 2008, RxElite was awarded the contract listing for all classes of trade for Sojourn(TM) (Sevoflurane) and Terrell(TM) (Isoflurane). Sevoflurane is the most commonly used anesthetic gas in the United States and Isoflurane continues to be used widely in anesthesia practice.

"We are excited to partner with Nueterra. The agreement has already begun to yield significant cost savings to the members of Nueterra," stated Jonathan Houssian, the CEO of RxElite.

RxElite anesthetic gases are manufactured by MINRAD International, Inc. (AMEX: BUF), a leader in the innovation of anesthesia. RxElite holds the exclusive distribution rights for Minrad-produced anesthetic gases for the human market in the United States.

About RxElite, Inc.

RxElite, Inc. develops, manufactures, and markets generic prescription drug products in specialty generic markets. These markets include products in the areas of anesthesia, sterile liquid dose drugs (including respiratory inhalation drugs, ophthalmics, and injectable drugs), complex active pharmaceutical ingredients, and other specialty areas. www.RxElite.com

About MINRAD International, Inc.

MINRAD International, Inc. is an interventional pain management company with real-time image guidance and anesthesia and analgesia product lines, and also manufactures and markets generic inhalation anesthetics for use in connection with human and veterinary surgical procedures. The company is developing a drug/drug delivery system for conscious sedation, which, similar to nitrous oxide in dental surgery, provides a patient with pain relief without loss of consciousness. www.minrad.com

About Nueterra Healthcare

Since 1997, Nueterra Healthcare has provided development and management services for single and multi-specialty ambulatory surgery centers, specialty hospitals, physical therapy centers and medical real estate. Nueterra Healthcare currently owns and manages more than 80 surgical and outpatient facilities in 27 states across the United States.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 involving known and unknown risks, delays, and uncertainties that may cause our actual results or performance to differ materially from those expressed or implied by these forward-looking statements. These risks, delays, and uncertainties include, but are not limited to: risks associated with the uncertainty of future financial results, our reliance on our sole supplier, the limited diversification of our product offerings, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

For more information: Corporate Information Ph: (208) 288-5550 Toll Free: (800) 414-1901 Fax: (208) 288-1191 Investor Relations Ric Tener Ph: (208) 288-5550 Fax: (208) 288-1191 Email: Email Contact

RXElite (CE) (USOTC:RXEI)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more RXElite (CE) Charts.
RXElite (CE) (USOTC:RXEI)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more RXElite (CE) Charts.